Banque Pictet & Cie’s Moderna MRNA Stock Holding History

Banque Pictet & Cie’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$189M	Sell	2,699,402 -49,352	-2%	-$2.55M	1.18%	15
2026 Q1	$140M	Sell	2,748,754 -381,970	-12%	-$17.8M	0.98%	15
2025 Q4	$92.3M	Hold	3,130,724	–	–	0.54%	20
2025 Q3	$80.9M	Sell	3,130,724 -2,250	-0.1%	-$62.8K	0.47%	22
2025 Q2	$86.4M	Hold	3,132,974	–	–	0.6%	22
2025 Q1	$88.8M	Hold	3,132,974	–	–	0.72%	23
2024 Q4	$130M	Sell	3,132,974 -22,425	-0.7%	-$1.07M	0.87%	18
2024 Q3	$211M	Buy	3,155,399 +970	+0%	+$89.1K	1.6%	16
2024 Q2	$375M	Sell	3,154,429 -7,300	-0.2%	-$924K	3.39%	13
2024 Q1	$337M	Buy	3,161,729 +27,500	+0.9%	+$2.77M	3.16%	13
2023 Q4	$312M	Sell	3,134,229 -9,198	-0.3%	-$774K	2.58%	14
2023 Q3	$325M	Buy	3,143,427 +47,788	+2%	+$5.33M	3.83%	9
2023 Q2	$376M	Sell	3,095,639 -13,196	-0.4%	-$1.76M	3.3%	10
2023 Q1	$477M	Buy	3,108,835 +27,398	+0.9%	+$4.52M	4.63%	6
2022 Q4	$553M	Buy	3,081,437 +57,256	+2%	+$9.36M	5.77%	1
2022 Q3	$358M	Sell	3,024,181 -2,165	-0.1%	-$329K	3.9%	7
2022 Q2	$432K	Buy	3,026,346 +26,863	+0.9%	+$3.84M	4.28%	4
2022 Q1	$517M	Buy	2,999,483 +15,604	+0.5%	+$2.63M	3.99%	5
2021 Q4	$758M	Sell	2,983,879 -19,530	-0.7%	-$5.71M	5.61%	3
2021 Q3	$1.16B	Sell	3,003,409 -13,760	-0.5%	-$5.07M	12.04%	1
2021 Q2	$709M	Sell	3,017,169 -22,240	-0.7%	-$3.97M	7.91%	2
2021 Q1	$398M	Buy	3,039,409 +19,400	+0.6%	+$2.81M	5.1%	2
2020 Q4	$316M	Sell	3,020,009 -132,437	-4%	-$13.4M	4.29%	7
2020 Q3	$223M	Sell	3,152,446 -140,500	-4%	-$9.8M	3.37%	10
2020 Q2	$211M	Sell	3,292,946 -236,068	-7%	-$12.9M	3.54%	11
2020 Q1	$106M	Sell	3,529,014 -383,523	-10%	-$8.82M	2.18%	15
2019 Q4	$76.5M	Sell	3,912,537 -37,314	-0.9%	-$662K	1.33%	18
2019 Q3	$62.9M	Buy	3,949,851 +30,000	+0.8%	+$443K	1.19%	18
2019 Q2	$57.4M	Buy	+3,919,851	New	+$84.2M	1.06%	21

Other funds holding MRNA

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

OIAM

OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

CNB

Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

COPPSERS

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return

Banque Pictet & Cie's MRNA Position: Q2 2026 in Review

Banque Pictet & Cie reduced its Moderna (MRNA) stake by 1.8% in Q2 2026, selling an estimated $2.55M and leaving 2,699,402 shares worth $189M. The position accounts for 1.18% of the portfolio, ranked #15.

Banque Pictet & Cie first reported a position in MRNA in Q2 2019 and has held it in 29 quarters since. The position peaked at $1.16B in Q3 2021. 184 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

Banque Pictet & Cie held 2,699,402 shares of Moderna worth $189M as of Q2 2026.
Banque Pictet & Cie sold 49,352 Moderna shares in Q2 2026, an estimated $2.55M.
Moderna made up 1.18% of Banque Pictet & Cie's portfolio in Q2 2026, its #15 holding.
Banque Pictet & Cie first reported a position in Moderna in Q2 2019 and has held it in 29 quarters since.
Banque Pictet & Cie's Moderna position peaked at $1.16B in Q3 2021.
184 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Banque Pictet & Cie's 13F filing for Q2 2026, filed 24 Jul 2026.